MSAC may delay big PBAC outcomes

By Megan Brodie 3 years ago | In Cell and gene therapies, MedTech
  • 3 years ago

5 April 2024 A PBAC decision on the first Alzheimer’s therapy to be considered by…

This is subscriber-only content. Please login to continue reading.